Evonik invests $100M

Evonik to invest $100M in drug substance manufacturing site in Indiana

Evonik will invest $100 million over five years to modernize its Lafayette, Indiana facility, enhancing API manufacturing capabilities and automation. This strategic move aims to meet growing US deman